Update for year-end 3 for work being done to optimize a cell-based cancer vaccine approach to improving outcomes in dogs with non-Hodgkins lymphoma.
Update from the end of year 2 of research underway by Dr. Iivanainen of University of Helsinki to hopefully lead to a genetic test to aid breeders in controlling hip dysplasia.
RALEIGH, N.C. – The AKC Canine Health Foundation (CHF), a nonprofit organization dedicated to preventing, treating, and curing diseases in all dogs, is pleased to announce the funding of an exciting grant which aims to better understand and prevent hemangiosarcoma, an aggressive form of cancer in dogs. Three groups whose dogs have been affected by this cruel disease — the American Boxer Charitable Foundation, the Golden Retriever Foundation, and the Portuguese Water Dog Foundation — are taking a unique, collaborative stand against cancer by pledging $432,000 to support this research effort.
Continue reading “AKC Canine Health Foundation Announces $432,000 Grant to Fight Cancer in Dogs”
Final results for work from Dr. Pedro L Boscan, DVM, PhD of Colorado State University looking into the prospect of using the SmartPill device for at home diagnostics in canine gastrointestinal disorders.
PARKER FORD, PA, October 1, 2015 15:00 ET — In an unprecedented collaboration, the Portuguese Water Dog Foundation is pleased and excited to announce that we have signed a Memorandum of Understanding with the Golden Retriever Foundation, the American Boxer Charitable Foundation and the AKC Canine Health Foundation for a joint research project to develop two technologies that will allow researchers to diagnose hemangiosarcoma in the early stages and to treat the disease before it reaches the crisis point.
Update on findings at the end of year 1 in a study to develop a generalized understanding of the impact of early spay and neuter on disease risk in dogs. The goal of this project is to evaluate, using one consistent and uniform database at their large veterinary medical center (UC Davis).
Update from the middle of year 1 in the clinical trial to establish evidence-base use of regenerative medicine in the treatment of tendon injury in dogs.
Update from the middle of year 2 of research underway by Dr. Iivanainen of University of Helsinki to hopefully lead to a genetic test to aid breeders in controlling hip dysplasia.
Update for year-end 2 for work being done to optimize a cell-based cancer vaccine approach to improving outcomes in dogs with non-Hodgkins lymphoma.
This research update provides information mid-year 2 of a 3-year project looking at prevention, diagnosis, and treatment of cancer in dogs. Principle investigators are Modiano, Breen, and Lindblad-Toh.